HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study.

AbstractOBJECTIVE:
The prevalence of thrombotic cerebral infarction is higher in dialysis than in general patients. Changes in cerebral blood flow (CBF) during low-density lipoprotein cholesterol-apheresis (LDL-A) in dialysis patients with arteriosclerosis obliterans (ASO) were evaluated employing xenon-CT (Xe-CT) to investigate the possibility of CBF improvement.
SUBJECTS AND METHODS:
Xe-CT was performed before LDL-A in 4 dialysis patients with ASO (3 males and 1 female). LDL-A was then performed once a week 10 times. After the completion of LDL-A treatment, Xe-CT was performed again to observe changes in CBF.
RESULTS:
Before treatment, CBF in the 4 patients was lower than that in the general population in the same age group. After LDL-A treatment, CBF was improved. The improvement was observed in the cerebral cortex rather than the basal ganglia. The grade of improvement and improved cerebral region varied among the patients.
CONCLUSION:
It was suggested that LDL-A may improve not only lower limb blood flow but also CBF. However, further investigation is necessary with regard to the influence of CBF improvement on the brain function and clinical application. The reported results need to be confirmed in larger studies.
AuthorsFumitaka Nakajima, Satoshi Morimoto, Takatomi Yurugi, Yoshihumi Amari, Yuko Kasuno, Masayoshi Fukui, Yoshiyuki Furumatsu, Tetsuya Kitamura
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 35 Issue 11 Pg. 981-5 (Nov 2012) ISSN: 1724-6040 [Electronic] United States
PMID23065872 (Publication Type: Journal Article)
Chemical References
  • Lipoproteins, LDL
Topics
  • Aged
  • Arteriosclerosis Obliterans (complications, physiopathology, therapy)
  • Blood Component Removal
  • Cerebral Infarction (prevention & control)
  • Cerebrovascular Circulation (physiology)
  • Cohort Studies
  • Female
  • Humans
  • Kidney Failure, Chronic (complications, physiopathology, therapy)
  • Lipoproteins, LDL
  • Male
  • Middle Aged
  • Pilot Projects
  • Renal Dialysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: